^
    BIOMARKER:

    BCR-ABL1 T315I

    i
    Other names: ABL proto-oncogene 1, ABL, c-ABL, JTK7, p150, ABL1, BCR, BCR Activator Of RhoGEF And GTPase, BCR, RhoGEF And GTPase Activating Protein, Breakpoint Cluster Region Protein, Renal Carcinoma Antigen NY-REN-26, Breakpoint Cluster Region, D22S11, BCR1, BCR/FGFR1 Chimera Protein, FGFR1/BCR Chimera Protein, D22S662, ALL, CML, PHL




    Show legend

    Include preclinical:
    Chronic Myeloid Leukemia
    B Acute Lymphoblastic Leukemia
    Acute Lymphocytic Leukemia
    Non-Hodgkin’s Lymphoma
    Leukemia
    olverembatinib
    ponatinib
    asciminib
    T-lymphocyte cell therapy
    imatinib
    PF-114
    VPD
    Tyrosine kinase inhibitor
    TGRX-678
    axitinib
    dasatinib + axitinib
    ponatinib + asciminib
    IODVA1
    dasatinib
    venetoclax
    PD-0325901
    axitinib + asciminib
    KF-1601
    NT-157
    bosutinib
    nilotinib
    sorafenib
    CUDC-907
    dasatinib + nilotinib
    ponatinib + GMX1778